Pfizer is working with leading non-profit organizations, governments, the United Nations and the World Health Organization to build partnerships for a healthier world. Some of the initiatives we operate across the world include:
Targeted Area: Ghana, Kenya and Senegal
Date: 2007-2011
Pfizer’s Commitment: A five-year, three-country initiative that engages and educates treatment providers and patients to improve the utilization and effectiveness of malaria treatment and patient adherence
Partners: London School of Hygiene and Tropical Medicine, KEMRI-Wellcome Trust, Population Services International (PSI), Health Partners Ghana, Family Health International/Ghana Social Marketing Foundation (GSMF), Intrahealth International
.jpeg)
Goal: To provide treatment for AIDS-related fungal infections in developing countries where HIV/AIDS is endemic
Targeted Area: Developing countries with priority given to those countries with greater than 1 percent HIV/AIDS prevalence
Start Date: 2000
Pfizer's Commitment: To provide fluconazole, an antifungal to treat two fungal opportunistic infections associated with AIDS, free of charge to governmental and nongovernmental organizations in developing countries with a greater that 1% prevalence of HIV/AIDS.
Partners: Axios International, International Dispensary Association (IDA), IMA World Health, governments and NGOs
Successes:
More than $840 million in medicine donated to more than 2000 sites in 60 countries in Africa, Asia, the Caribbean and Latin America
More than 20,000 health professionals trained in the diagnosis and treatment of fungal opportunistic infections
Goal: To build capacity in Africa for the delivery of sustainable, high quality care and prevention of HIV/AIDS and related infectious diseases through training and research
Targeted Area: Sub-Saharan Africa, centered in Uganda
Start Date: 2001
Pfizer's Commitment: Support for the building of a regional treatment, research and training institute in Kampala, Uganda to strengthen local and regional capacity in HIV/AIDS care
Partners: Makerere University, Accordia Global Health Foundation, the Infectious Diseases Society of America and The AIDS Support Organization (TASO) among others
Successes:
Trained more than 3,500 health care providers from 27 African countries
Currently providing care to approximately 10,000 patients
Building research capacity in Africa by pairing promising new investigators with established researchers from North America and Europe, and through mentoring arrangements and fellowships
Goal: To support innovative public health partnerships that will serve as global models in improving cancer-related health outcomes and/or supporting cancer or tobacco control efforts
Targeted Area: Asia, Africa, Latin America, Middle East, Europe, and the U.S.
Start Date: 2007
Pfizer's Commitment: The Pfizer Foundation, together with the Pfizer country offices will commit $47 million over the next four years (2007-2010).
Partners: Pfizer's partners include: Action on Smoking and Health (ASH) International, Akebono-Kai, American Cancer Society, China Tobacco Control Association, Korean National Council of Women, European Organization for Research and Treatment of Cancer (EORTC), International Union Against Cancer (UICC), Japan Dental-Medical Association for Tobacco Council, Mexican Council on Tobacco, Philippine Business for Social Progress, QUIT UK/European Network of Quitlines, Shanghai Municipal Center for Disease Control and Prevention, The New Hope in Health Foundation, The Ralph Lauren Center for Cancer Care and Prevention and The Veronesi Foundation.
The grants will be managed by three intermediaries: the King Baudouin Foundation, Give 2 Asia, TCC Group, and The Resource Foundation with oversight from the Pfizer Foundation. The Johns Hopkins University-Bloomberg School of Public Health will provide technical assistance and evaluation support.
Goal: To eliminate trachoma, the world's leading cause of preventable blindness
Targeted Area: The developing world
Start Date: 1998
Pfizer's Commitment: Donations of the antibiotic azithromycin and support for community-based training and education initiatives
Partners: Task Force for Child Survival and Development, World Health Organization, Gates Foundation, Carter Center, Lions Club International, USAID, and the Edna McConnell Clark Foundation among others
Successes:
More than 145 million treatments of Zithromax® donated for use in 18 countries
More than 416,000 surgeries performed to treat advanced cases of trichiasis, the advanced and blinding stage of trachoma
Thousands of health care workers trained in trachoma treatment
In 2006, Morocco became the first country to complete the campaign for trachoma control and is working toward WHO certification that blinding trachoma has been eliminated as a public health problem.
Targeted Area: 10 states with the highest number of new AIDS cases: New York, Florida, California, Texas, New Jersey, Illinois, Georgia, Pennsylvania, Maryland and North Carolina
Start Date: 2007-2009
Pfizer’s Commitment: $7.5 million over 3 years to:
Partners: Academy for Educational Development, John Hopkins University, Black Coalition on AIDS, STOP AIDS Project, AIDS Interfaith Residential Services, Latino Commission on AIDS, BEBASHI, St. Hope Foundation, Northeast Florida AIDS Network (NFAN), New York Harm Reduction Educators, Prevention Point Philadelphia, California Prevention and Education Project (CAL-PEP), Foothill AIDS Project, Positive Impact, AIDS Care Services (ACS), Piedmont Health Care Consortium, Hyacinth AIDS Foundation, Philadelphia FIGHT, Shanti Project, Chicago House and Social Service Agency, Test Positive Aware Network, The Family Center
.jpeg)
Targeted Area: Asia, Africa, Latin America, Middle East, Europe, and the U.S.
Start Date: 2007
Pfizer's Commitment: The Pfizer Foundation, together with the Pfizer country offices will commit $47 million over the next four years (2007-2010).
Partners: Pfizer's partners include: Action on Smoking and Health (ASH) International, Akebono-Kai, American Cancer Society, China Tobacco Control Association, Korean National Council of Women, European Organization for Research and Treatment of Cancer (EORTC), International Union Against Cancer (UICC), Japan Dental-Medical Association for Tobacco Council, Mexican Council on Tobacco, Philippine Business for Social Progress, QUIT UK/European Network of Quitlines, Shanghai Municipal Center for Disease Control and Prevention, The New Hope in Health Foundation, The Ralph Lauren Center for Cancer Care and Prevention and The Veronesi Foundation.
The grants will be managed by three intermediaries: the King Baudouin Foundation, Give 2 Asia, TCC Group, and The Resource Foundation with oversight from the Pfizer Foundation. The Johns Hopkins University-Bloomberg School of Public Health will provide technical assistance and evaluation support.
Goal: To support innovative public health partnerships that will serve as global models in improving cancer-related health outcomes and/or supporting cancer or tobacco control effortsGoal: To complement existing HIV prevention efforts and help stop the spread of HIV/AIDS by supporting integrated approaches that bring together prevention, access to care and treatment. Goal: To help close critical gaps in malaria treatment and education in Africa